Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa

被引:18
|
作者
Cheng, Chih-Yuan [1 ,2 ,3 ]
Quaife, Matthew [1 ]
Eakle, Robyn [4 ]
Escobar, Maria A. Cabrera [4 ]
Vickerman, Peter [5 ]
Terris-Prestholt, Fern [1 ]
机构
[1] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England
[2] Heidelberg Univ, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
[3] German Canc Res Ctr, Div Hlth Econ, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[4] Univ Witwatersrand, Wits RHI, 22 Esselen St, ZA-2001 Johannesburg, South Africa
[5] Univ Bristol, Sch Social & Community Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England
基金
英国经济与社会研究理事会;
关键词
HIV prevention; Long-acting injectable pre-exposure prophylaxis; Heterosexual men; South Africa; Biomedical strategies; ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; INFECTION; SEX; RISK; PREFERENCES; TRANSMISSION; WILLINGNESS; PERCEPTIONS; TENOFOVIR;
D O I
10.1186/s12889-019-7276-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundHeterosexual men in South Africa are a large key population to exposure to HIV, yet preferences for HIV pre-exposure prophylaxis (PrEP) among this population have not, to date, been investigated in the literature. This paper aims to explore HIV prevention preferences among heterosexual men in urban South Africa, as well as to examine the demand and characteristics of men who favour long-acting injectable (LAI) PrEP over condoms and oral PrEP.MethodsData were collected among 178 self-reported HIV-negative heterosexual men, who were given example products and information before being asked which they preferred. Multivariate logistic regression was used to analyse which characteristics were associated with product choice.Results48% (n=85) of participants preferred LAI PrEP, while 33% (n=58) and 20% (n=35) chose oral PrEP and condoms respectively. Having children (marginal effect=0.22; 95% CI [0.01, 0.44]) or having higher risk attitude scores (marginal effect=0.03; 95% CI [0.01, 0.06]) was significantly associated with a choice of LAI PrEP, while those who had unprotected anal intercourse (marginal effect=-0.42; 95% CI [-0.57, -0.27]) and those who were concerned with protection against other sexually transmitted infections over HIV (marginal effect=-0.42; 95% CI [-0.60, -0.24]) appeared less likely to prefer LAI PrEP.ConclusionsThe results suggested a relatively high demand and theoretical acceptability for LAI PrEP among heterosexual men in urban South Africa, but there appeared to be fewer distinct predictors for the willingness to use LAI PrEP compared to studies conducted among gay and bisexual men and women. Nevertheless, the findings contribute to the mapping of the demand and determinants of heterosexual men's preferences for novel antiretroviral-based prevention in sub-Saharan Africa, and the data could aid in the differentiated design of future HIV prevention strategies using LAI PrEP in conjunction with other methods.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
    Zondo, Nomusa M.
    Sobia, Parveen
    Sivro, Aida
    Ngcapu, Sinaye
    Ramsuran, Veron
    Archary, Derseree
    FRONTIERS IN GENETICS, 2022, 13
  • [22] Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
    Brogan, Anita J.
    Davis, Ashley E.
    Mellott, Claire E.
    Fraysse, Jeremy
    Metzner, Aimee A.
    Oglesby, Alan K.
    PHARMACOECONOMICS, 2024, 42 (04) : 447 - 461
  • [23] Interest in Long-Acting Injectable Pre-exposure Prophylaxis (LAI PrEP) Among Women in the Women's Interagency HIV Study (WIHS): A Qualitative Study Across Six Cities in the United States
    Philbin, Morgan M.
    Parish, Carrigan
    Kinnard, Elizabeth N.
    Reed, Sarah E.
    Kerrigan, Deanna
    Alcaide, Maria L.
    Cohen, Mardge H.
    Sosanya, Oluwakemi
    Sheth, Anandi N.
    Adimora, Adaora A.
    Cocohoba, Jennifer
    Goparaju, Lakshmi
    Golub, Elizabeth T.
    Fischl, Margaret
    Metsch, Lisa R.
    AIDS AND BEHAVIOR, 2021, 25 (03) : 667 - 678
  • [24] EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP)
    Kaul, Christina M.
    Moore, Brandi E.
    Kaplan-Lewis, Emma
    Casey, Eunice
    Pitts, Robert A.
    Pirallo, Patricia Pagan
    Lim, Sahnah
    Kapadia, Farzana
    Cohen, Gabriel M.
    Khan, Maria
    Mgbako, Ofole
    PLOS ONE, 2023, 18 (09):
  • [25] Gay and Bisexual Men's Perceptions of Pre-exposure Prophylaxis (PrEP) in a Context of High Accessibility: An Australian Qualitative Study
    Philpot, Steven
    Prestage, Garrett
    Holt, Martin
    Haire, Bridget
    Maher, Lisa
    Hammoud, Mo
    Bourne, Adam
    AIDS AND BEHAVIOR, 2020, 24 (08) : 2369 - 2380
  • [26] Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women
    Weeden, Terrance
    Garofalo, Robert
    Johnson, Amy K.
    Schnall, Rebecca
    Scherr, Thomas
    Kuhns, Lisa M.
    Cervantes, Marbella
    ACADEMIC PEDIATRICS, 2024, 24 (07) : 1110 - 1115
  • [27] Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment
    Minnis, Alexandra M.
    Atujuna, Millicent
    Browne, Erica N.
    Ndwayana, Sheily
    Hartmann, Miriam
    Sindelo, Siyaxolisa
    Ngcwayi, Nangamso
    Boeri, Marco
    Mansfield, Carol
    Bekker, Linda-Gail
    Montgomery, Elizabeth T.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (06)
  • [28] A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California
    Beltran, Raiza M.
    Hunter, Lauren A.
    Packel, Laura J.
    De Martini, Loriann
    Holloway, Ian W.
    Dong, Betty J.
    Lam, Jerika
    Mccoy, Sandra I.
    Ochoa, Ayako Miyashita
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 97 (02) : 142 - 149
  • [29] Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
    Atuhaire, Bridget
    Muteebwa, Laban
    Nabunya, Racheal
    Muhindo, Richard
    Ngabirano, Tom Denis
    Osingada, Charles Peter
    Muwanguzi, Patience A.
    AIDS RESEARCH AND THERAPY, 2024, 21 (01):
  • [30] Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States
    Parsons, Jeffrey T.
    Rendina, Jonathon
    Lassiter, Jonathan M.
    Whitfield, Thomas H. F.
    Starks, Tyrel J.
    Grov, Christian
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (03) : 285 - 292